373 related articles for article (PubMed ID: 18191522)
1. [Strongyloides stercoralis hyperinfection syndrome with acute meningoencephalitis associated to HTLV-1 and HTLV-2 virus co-infection].
N'dri K; Kouame KE; Sahari R; Hommel D; Hulin A
Med Mal Infect; 2008 Mar; 38(3):162-4. PubMed ID: 18191522
[No Abstract] [Full Text] [Related]
2. Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis.
Carvalho EM; Da Fonseca Porto A
Parasite Immunol; 2004; 26(11-12):487-97. PubMed ID: 15771684
[TBL] [Abstract][Full Text] [Related]
3. Strongyloides stercoralis hyperinfection associated with human T cell lymphotropic virus type-1 infection in Peru.
Gotuzzo E; Terashima A; Alvarez H; Tello R; Infante R; Watts DM; Freedman DO
Am J Trop Med Hyg; 1999 Jan; 60(1):146-9. PubMed ID: 9988339
[TBL] [Abstract][Full Text] [Related]
4. Secondary Strongyloides stercoralis prophylaxis in patients with human T-cell lymphotropic virus type 1 infection: report of two cases.
Peters L; McCarthy AE; Faught C
Int J Infect Dis; 2009 Nov; 13(6):e501-3. PubMed ID: 19501008
[TBL] [Abstract][Full Text] [Related]
5. Reduced efficacy of treatment of strongyloidiasis in HTLV-I carriers related to enhanced expression of IFN-gamma and TGF-beta1.
Satoh M; Toma H; Sato Y; Takara M; Shiroma Y; Kiyuna S; Hirayama K
Clin Exp Immunol; 2002 Feb; 127(2):354-9. PubMed ID: 11876761
[TBL] [Abstract][Full Text] [Related]
6. Strongyloidiasis associated with human T-cell lymphotropic virus type I infection in a nonendemic area.
Dixon AC; Yanagihara ET; Kwock DW; Nakamura JM
West J Med; 1989 Oct; 151(4):410-3. PubMed ID: 2588581
[TBL] [Abstract][Full Text] [Related]
7. Fatal outcome in a patient under immunosuppressant therapy infected with human T-lymphotropic virus type 1 (HTLV-1), cytomegalovirus (CMV) and Strongyloides stercoralis: a case report.
Ashida C; Kinoshita K; Nozaki Y; Funauchi M
BMC Infect Dis; 2020 Jul; 20(1):470. PubMed ID: 32615937
[TBL] [Abstract][Full Text] [Related]
8. [Human T-lymphotropic virus 1 (HTLV-1), strongyloidiasis and scabies. Infections and associations to considerate].
Freites A
Invest Clin; 2008 Dec; 49(4):455-6. PubMed ID: 19245164
[TBL] [Abstract][Full Text] [Related]
9. [Strongyloides stercoralis hyperinfection syndrome in a Colombian patient receiving immunosuppressive treatment].
Rojo-Marcos G; Cuadros-González J; González-Juárez MJ; Gómez-Ayerbe C
Enferm Infecc Microbiol Clin; 2009; 27(7):432-4. PubMed ID: 19477050
[No Abstract] [Full Text] [Related]
10. [Hyperinfection by Strongyloides stercoralis in a patient with ulcerative colitis].
López Gallardo A; Díez García F; Yélamos F; Orozco F
Enferm Infecc Microbiol Clin; 1997 May; 15(5):273. PubMed ID: 9376389
[No Abstract] [Full Text] [Related]
11. [Respiratory and renal insufficiency in a COPD patient receiving corticoid treatment].
Tirado MD; Gil M; Galiano J; Pardo F; Moreno R; Del Busto AG; Sabater S; Gomila B
Enferm Infecc Microbiol Clin; 2002 Oct; 20(8):401-2. PubMed ID: 12372237
[No Abstract] [Full Text] [Related]
12. Regulatory T cell expansion in HTLV-1 and strongyloidiasis co-infection is associated with reduced IL-5 responses to Strongyloides stercoralis antigen.
Montes M; Sanchez C; Verdonck K; Lake JE; Gonzalez E; Lopez G; Terashima A; Nolan T; Lewis DE; Gotuzzo E; White AC
PLoS Negl Trop Dis; 2009 Jun; 3(6):e456. PubMed ID: 19513105
[TBL] [Abstract][Full Text] [Related]
13. [Aseptic purulent meningitis in two patients co-infected by HTLV-1 and Strongyloides stercoralis].
Foucan L; Genevier I; Lamaury I; Strobel M
Med Trop (Mars); 1997; 57(3):262-4. PubMed ID: 9513154
[TBL] [Abstract][Full Text] [Related]
14. Atypical clinical presentation of strongyloidiasis in a patient co-infected with human T cell lymphotrophic virus type I.
Porto MA; Alcântara LM; Leal M; Castro N; Carvalho EM
Am J Trop Med Hyg; 2005 Feb; 72(2):124-5. PubMed ID: 15741545
[TBL] [Abstract][Full Text] [Related]
15. [Combined infection with HTLV-1 and Strongyloides stercoralis].
Pays JF
Bull Soc Pathol Exot; 2011 Aug; 104(3):188-99. PubMed ID: 21800110
[TBL] [Abstract][Full Text] [Related]
16. Treatment failure in intestinal strongyloidiasis: an indicator of HTLV-I infection.
Terashima A; Alvarez H; Tello R; Infante R; Freedman DO; Gotuzzo E
Int J Infect Dis; 2002 Mar; 6(1):28-30. PubMed ID: 12044298
[TBL] [Abstract][Full Text] [Related]
17. Subcutaneous ivermectin as a safe salvage therapy in Strongyloides stercoralis hyperinfection syndrome: a case report.
Pacanowski J; Santos MD; Roux A; LE Maignan C; Guillot J; Lavarde V; Cornet M
Am J Trop Med Hyg; 2005 Jul; 73(1):122-4. PubMed ID: 16014846
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous manifestation of disseminated strongyloidiasis in a patient coinfected with HTLV-I.
Arch EL; Schaefer JT; Dahiya A
Dermatol Online J; 2008 Dec; 14(12):6. PubMed ID: 19265619
[TBL] [Abstract][Full Text] [Related]
19. Strongyloides stercoralis hyperinfection in systemic lupus erythematosus and the antiphospholipid syndrome.
Mora CS; Segami MI; Hidalgo JA
Semin Arthritis Rheum; 2006 Dec; 36(3):135-43. PubMed ID: 16949135
[TBL] [Abstract][Full Text] [Related]
20. Strongyloides stercoralis: a rare and severe presentation in a pregnant woman.
Beltrán Rosel A; Sanjoaquín Conde I; Pérez Muñoz A; Alcalá PM; Marta CB; Irigoyen von Sierakowski A
New Microbiol; 2020 Jan; 43(1):44-46. PubMed ID: 31814031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
